clearsidebio.com - CLSD Profit before interest, taxes and amortization

Brandmark of Clearside Biomedical, Inc. (CLSD)

Clinic transparency and the patent protection of Clearside Biomedical (CLSD) guarantee business stability. Absolute EBITDA dynamics confirm this thesis, where 0.00 shows the value of this parameter. Revenues are based on the licensing of ocular drug delivery methods. Meanwhile, the growth of in-house R&D expenses is offset by royalties from partners, which constrains the company's overall margins.

Clearside Biomedical (CLSD) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 12/13/2025

Summary analytical data breakdowns for Clearside Biomedical, Inc. (CLSD)

- market value and analyst target forecast:
Market Price Clearside Corp|CLSD - Consensus Target
- issuer market value details:
Market Value Clearside Biomedical|CLSD - Enterprise Value
- book capitalization data:
Net Asset Value per Share Clearside Biomedical|CLSD - Company Book Value|Market Capitalization to Book Value clearsidebio.com|CLSD - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Clearside Biomedical|CLSD - Long-Term Debt to Equity|Short-Term Debt to Equity Clearside Biomedical Inc|CLSD - Company Aggregate Debts|Debts to Book Value Clearside Biomedical|CLSD - Company Long-Term Debts|Company Short-Term Debts Clearside Biomedical|Intermediate Coverage Ratio clearsidebio.com
- earnings and market multiples details:
CLSD - Company Net Income|Company Profit Forecast Clearside Biomedical|CLSD - P/E Multiple|Market Cap to Projected Earnings clearsidebio.com|CLSD - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Clearside Biomedical|CLSD - Operating profit EBITDA|Net earnings per one share for the last twelve months Clearside Biomedical|CLSD - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months clearsidebio.com|CLSD - Earnings growth in current year|Net earnings per share growth forecast for next year Clearside Biomedical
Summary company analytics:Clearside Biomedical
Mass-produced product of Clearside Biomedical Inc

The long-term reliability of Clearside Biomedical (CLSD) is determined by its ability to generate cash flow, which is reflected in the consolidated EBITDA through the monitoring of daily operational cash volume to identify hidden disruptions in business processes. This metric measures fundamental resilience to external shocks, confirming the financial viability of developing unique suprachoroidal drug delivery methods in US research centers.

Who Clearside Biomedical competes with

Alcon Corp (ALC) - Profit before interest, taxes and amortization|BLCO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization glaukos.com|APLS: Operating profit EBITDA|Profit before interest, taxes and amortization Belite Bio Pharma (BLTE)|Profit before payment of interest, taxes and amortization Ocular Therapeutix Corp|Harrow Corp (HROW) - Operating income before deduction of amortization|Operating profit EBITDA VRDN|Operating profit before deduction of amortization lenz-tx.com LENZ|Profit before payment of interest, taxes and amortization Oculis Holding OCS|EyePoint Pharmaceuticals Inc - Profit before payment of interest, taxes and amortization|Kodiak Pharma - Operating profit EBITDA|Profit before interest, taxes and amortization Aldeyra Therapeutics|KALA: Operating profit EBITDA|Opus Genetics (IRD) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization OKYO Pharma Ltd|ADVM: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Outlook Pharma (OTLK)|Operating income before deduction of amortization novabay.com|Operating profit EBITDA KPRX (Kiora Pharmaceuticals, Inc.)|Operating income before deduction of amortization Alimera Sciences Inc (ALIM)|Eyenovia Corp - Operating profit EBITDA|GHSI (Guardion Health Sciences, Inc.) - Operating profit before amortization|OCUP: Operating profit EBITDA|Profit before interest, taxes and amortization Opthea Corp (OPT)